Mostrar el registro sencillo del ítem

dc.contributor.authorMoyano, Ana
dc.contributor.authorBlanch-Lombarte, Oscar
dc.contributor.authorTarancon-Diez, Laura
dc.contributor.authorPedreño-Lopez, Nuria
dc.contributor.authorArenas, Miguel
dc.contributor.authorAlvaro-Cifuentes, Tamara 
dc.contributor.authorCasado, Concepcion 
dc.contributor.authorOlivares, Isabel 
dc.contributor.authorVera, Mar
dc.contributor.authorRodriguez, Carmen
dc.contributor.authorDel Romero, Jorge
dc.contributor.authorLopez-Galindez, Luis Cecilio 
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorPrado, Julia G
dc.contributor.authorPernas, Maria 
dc.date.accessioned2022-05-24T10:43:25Z
dc.date.available2022-05-24T10:43:25Z
dc.date.issued2022-03-26
dc.identifier.citationRetrovirology. 2022 Mar 26;19(1):6.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14484
dc.description.abstractBackground: Long-Term Non-Progressors (LTNPs) are untreated Human Immunodeficiency virus type 1 (HIV-1) infected individuals able to control disease progression for prolonged periods. However, the LTNPs status is temporary, as viral load increases followed by decreases in CD4 + T-cell counts. Control of HIV-1 infection in LTNPs viremic controllers, have been associated with effective immunodominant HIV-1 Gag-CD8 + T-cell responses restricted by protective HLA-B alleles. Individuals carrying HLA-B*14:02 control HIV-1 infection is related to an immunodominant Env-CD8 + T-cell response. Limited data are available on the contribution of HLA-B*14:02 CD8 + T -cells in LTNPs. Results: In this study, we performed a virological and immunological detailed analysis of an HLA-B*14:02 LNTP individual that lost viral control (LVC) 27 years after HIV-1 diagnosis. We analysed viral evolution and immune escape in HLA-B*14:02 restricted CD8 + T -cell epitopes and identified viral evolution at the Env-EL9 epitope selecting the L592R mutation. By IFN-γ ELISpot and immune phenotype, we characterized HLA- B*14:02 HIV-1 CD8 + T cell responses targeting, Gag-DA9 and Env-EL9 epitopes before and after LVC. We observed an immunodominant response against the Env-EL9 epitope and a decreased of the CD8 T + cell response over time with LVC. Loss of Env-EL9 responses was concomitant with selecting K588R + L592R mutations at Env-EL9. Finally, we evaluated the impact of Env-EL9 escape mutations on HIV-1 infectivity and Env protein structure. The K588R + L592R escape variant was directly related to HIV-1 increase replicative capacity and stability of Env at the LVC. Conclusions: These findings support the contribution of immunodominant Env-EL9 CD8 + T-cell responses and the imposition of immune escape variants with higher replicative capacity associated with LVC in this LNTP. These data highlight the importance of Env-EL9 specific-CD8 + T-cell responses restricted by the HLA-B*14:02 and brings new insights into understanding long-term HIV-1 control mediated by Env mediated CD8 + T-cell responses.es_ES
dc.description.sponsorshipMolecular Virology Laboratory was supported by grants SAF (2016-77894-R) from Ministerio de Economía y Competitividad (MINECO), ISCIII through the projects PI 13/02269, PI17/00164, PI16/0684, PI19/01127 (Co-funded by European Regional Development Fund/European Social Fund "Investing in your future"). The RIS-RETIC grants RD12/0017/0028, RD16/0025/0020 and RD16CIII/0002/0005. LTD was supported by the Instituto de Salud Carlos III (ISCIII) under grant agreement “CD20/00025” through the Sara Borrell Program. O.B.L was funded by an AGAUR-FI_B 00582 Ph.D. fellowship from the Catalan Government and the European Social Fund. M.A. was funded by grants RYC-2015-18241 and PID2019-107931GA-I00 from the Spanish Government and, ED431F 2018/08 from the “Xunta de Galicia”. ERM was supported by the Spanish National Research Council (CSIC). JGP laboratory was supported by National Health Institute Carlos III grant PI17/00164 and Redes Temáticas de Investigación en SIDA (ISCIII RETIC RD16/0025/0041). The funders had no role in study design, data collection and analysis, the decision to publish or drafting of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCD8 + T-cellses_ES
dc.subjectEnv-EL9 escape HLA-B*14:02es_ES
dc.subjectLong-term non-progressor (LTNP)es_ES
dc.subjectLoss of viral control (LVC)es_ES
dc.titleImmunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 controles_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID35346235es_ES
dc.format.volume19es_ES
dc.format.number1es_ES
dc.format.page6es_ES
dc.identifier.doi10.1186/s12977-022-00591-7es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España) es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.contributor.funderUnión Europea. Fondo Social Europeo (ESF/FSE) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderAgència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) es_ES
dc.contributor.funderGovernment of Catalonia (España) es_ES
dc.contributor.funderGovernment of Spain es_ES
dc.contributor.funderXunta de Galicia (España) es_ES
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España) es_ES
dc.contributor.funderRETICS-Sida (RIS-ISCIII) (España) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1742-4690es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12977-022-00591-7es_ES
dc.identifier.journalRetrovirologyes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF-2016-77894es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RD12/0017/0028es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0020/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/ es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-107931GA-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0041/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/ es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI13/02269es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI17/00164es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI16/0684es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI19/01127es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CD20/00025es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0005es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional